Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
| ▸ | BRD2 | P25440 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18300763 | 0.90 | TSHR (0.47) | KMT2ATSHRPIK3CDLMNAMEN1 | |
| SCHEMBL24774945 | 0.90 | KMT2A (0.47) | KMT2ATSHRPIK3CDMEN1RAB9A | |
| SCHEMBL24015908 | 0.84 | KMT2A (0.49) | KMT2ATSHRPIK3CDLMNAMEN1 | |
| SCHEMBL13804326 | 0.82 | KMT2A (0.54) | KMT2ATSHRPIK3CDLMNAMEN1 | |
| SCHEMBL14235642 | 0.79 | TSHR (0.48) | KMT2ATSHRPIK3CDLMNAMEN1 | |
| Methacrylic Acid SCHEMBL1817345 | 0.79 | KMT2A (0.48) | KMT2ATSHRPIK3CDMEN1PKM | |
| SCHEMBL4076721 | 0.78 | KMT2A (0.50) | KMT2ATSHRPIK3CDLMNAMEN1 | |
| SCHEMBL443220 | 0.77 | TSHR (0.53) | KMT2ATSHRPIK3CDLMNAMEN1 | |
| SCHEMBL9471187 | 0.77 | TSHR (0.54) | KMT2ATSHRPIK3CDLMNA | |
| SCHEMBL163326 | 0.76 | KMT2A (0.46) | KMT2ATSHRPIK3CDMEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8722600-B2 | Polymers with H-bridge forming functionalities for improving anti-wear protection | EVONIK ROHMAX ADDITIVES GMBH (DE) | 2014-05-13 | — | — | US | disclosed |
| US-8476387-B2 | Catalytic process for preparing (meth)acrylic esters of N-hydroxyalkylated lactams | BASF SE (DE) | 2013-07-02 | — | — | US | disclosed |
| CN-101300220-B | Catalytic process for preparing (meth) acrylic esters from N-hydroxyalkylated lactams | BASF AG | 2013-02-20 | — | — | CN | disclosed |
| CN-101622228-B | Catalytic process for preparing (meth) acrylic esters of N-hydroxyalkylated lactams | BASF SE | 2013-01-09 | — | — | CN | disclosed |
| US-8349779-B2 | Polymers with h-bridge forming functionalities | EVONIK ROHMAX ADDITIVES GMBH (DE) | 2013-01-08 | — | — | US | disclosed |
| EP-1945602-B1 | HYDROGEN-CATALYSED PROCESS FOR PREPARING (METH)ACRYLATES OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2012-08-01 | — | — | EP | disclosed |
| US-7750100-B2 | Catalytic process for preparing (meth)acrylates from N-hydroxyalkylated lactams | BASF AKTIENGESELLSCHAFT (DE) | 2010-07-06 | — | — | US | disclosed |
| US-20100010236-A1 | CATALYTIC PROCESS FOR PREPARING (METH)ACRYLIC ESTERS OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2010-01-14 | — | — | US | disclosed |
| CN-101622228-A | Catalytic process for preparing (meth) acrylic esters of N-hydroxyalkylated lactams | BASF SE | 2010-01-06 | — | — | CN | disclosed |
| EP-2121595-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ESTERS OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2009-11-25 | — | — | EP | disclosed |
| CN-101300220-A | Catalytic process for preparing (meth) acrylic esters from N-hydroxyalkylated lactams | BASF AG (DE) | 2008-11-05 | — | — | CN | disclosed |
| WO-2008098885-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ESTERS OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2008-08-21 | — | — | WO | disclosed |
| EP-1945602-A1 | HYDROGEN-CATALYSED PROCESS FOR PREPARING (METH)ACRYLATES OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2008-07-23 | — | — | EP | disclosed |
| US-20070197409-A1 | Polymers with h-bridge forming functionalities for improving anti-wear protection | EVONIK DEGUSSA GMBH (DE) | 2007-08-23 | — | — | US | disclosed |
| US-20070184993-A1 | Polymers with h-bridge forming functionalities | ROHMAX ADDITIVES GMBH (DE) | 2007-08-09 | — | — | US | disclosed |
| US-20070123673-A1 | CATALYTIC PROCESS FOR PREPARING (METH)ACRYLATES FROM N-HYDROXYALKYLATED LACTAMS | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-31 | — | — | US | disclosed |
| WO-2007051738-A1 | HYDROGEN-CATALYSED PROCESS FOR PREPARING (METH)ACRYLATES OF N-HYDROXYALKYLATED LACTAMS | BASF SE (DE) | 2007-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100010236-A1 | CATALYTIC PROCESS FOR PREPARING (METH)ACRYLIC ESTERS OF N-HYDROXYALKYLATED LACTAMS | COASY, MCCC2, PAM | KMT2A 863/4885TSHR 2358/4885PIK3CD 1127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.